Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

This publication has 189 references indexed in Scilit:

• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
  Published by Elsevier ,2005
• Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk
  The Lancet, 2003
• ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article
  Journal of the American College of Cardiology, 2002
• ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
  Journal of the American College of Cardiology, 2002
• The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery
  New England Journal of Medicine, 1999
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial
  The American Journal of Cardiology, 1995
• Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women ≥62 years of age
  The American Journal of Cardiology, 1994
• The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers
  The Journal of Clinical Pharmacology, 1991
• Vasodilator Drugs in Peripheral Vascular Disease
  New England Journal of Medicine, 1979